サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Diabetes Therapies & Diagnostics: Global Markets

糖尿病治療薬および診断薬:世界市場

レポート概要

このレポートのポイント:

  • 糖尿病、糖尿病合併症治療薬などの治療薬;血糖測定器および付属品などの診断機器;その他あらゆるインターベンションに関する情報
  • 昨年のデータ、今年の推定データ、今後5年間の年間平均成長率予測を用いた世界市場の現状把握
  • 最新動向、特許の徹底分析を含む技術的課題のまとめ
  • 世界の2型糖尿病患者数予測に関する考察
  • 総合的な企業概要

調査の目的
このレポートの目的は糖尿病の治療に使用されるジェネリック医薬品、糖尿病の診断、モニタリングに使用される機器、検査装置の市場を定量的、定性的に把握するために、市場、技術、産業全体を詳細に調査、分析することにあります。重要な動向を探り、2015年までの製品分野別、主要国別売上予測を示します。これらは疫学データおよび予測に加え、各国の研究開発動向、市場の潜在能力に関する情報に基づいています。医療政策、人口統計、より広範な経済環境についても考察します。

レポート詳細

章ごとの価格

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Title / Chapter Name Pages Price
Diabetes Therapies & Diagnostics: Global Markets 150 $4,850
Chapter- 1: INTRODUCTION -- Complimentary 4 $0
Chapter-2: SUMMARY 2 $150
Chapter-3: OVERVIEW 6 $291
Chapter-4: ABOUT DIABETES 22 $1,067
Chapter-5: DIABETES THERAPIES 21 $1,019
Chapter-6: ORAL HYPOGLYCEMIC DRUGS 5 $243
Chapter-7: DIAGNOSIS AND MONITORING 29 $1,407
Chapter-8: THE DIABETES MARKET 17 $825
Chapter-9: NEW APPROACHES TO THE MANAGEMENT OF DIABETES 6 $291
Chapter-10: COMPANY PROFILES 31 $1,504
APPENDIX 7 $340

目次

Chapter- 1: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter-2: SUMMARY
THE DIABETES MARKET
LEADING COMPANIES
SUMMARY TABLE DIABETES MARKET BREAKDOWN BY PRODUCT GROUPS, THROUGH 2015 ($ BILLIONS)
SUMMARY FIGURE DIABETES MARKET EVOLUTION BY PRODUCT GROUP, 2010 AND 2015 ($ BILLIONS)

Chapter-3: OVERVIEW
DIABETES BASICS
A GROWING MARKET
DRUG TREATMENT OF DIABETES
INSULIN
ORAL ANTIDIABETIC DRUGS
THE PHARMACEUTICAL DIABETES MARKET
INSULIN ADMINISTRATION DEVICES
MEDICAL DEVICES FOR DIABETES
TABLE 1 TOTAL DIABETES MARKET ($)
REGIONAL SEGMENTATION
TABLE 2 ADULT DIABETES MARKET, BY REGION (MILLIONS/%)
MARKET GROWTH
THE DIABETES INDUSTRY
PHARMACEUTICAL COMPANIES
MEDICAL DEVICE COMPANIES

Chapter-4: ABOUT DIABETES
WHAT IS DIABETES?
BLOOD SUGAR REGULATION
INSULIN
TYPE 1 DIABETES
TYPE 2 DIABETES
GESTATIONAL DIABETES
OBESITY-RELATED TYPE 2 DIABETES IN CHILDREN
MATURE-ONSET DIABETES OF THE YOUNG (MODY)
OTHER DIABETIC STATES
DIAGNOSIS
GLUCOSE TESTS
OFFICIAL CRITERIA
DIFFERENTIAL DIAGNOSIS
Type 1 Diabetes
Type 2 Diabetes
CURRENT TREATMENT
TYPE 1 DIABETES
TABLE 3 MAIN BRANDS AND TYPES OF INSULIN
TYPE 2 DIABETES
Sulphonylureas
Biguanides
Alpha-glucosidase Inhibitors
Glitazones (Thiazolidinediones)
Prandial Glucose Regulators
Incretin Mimetics
DPP-4 Inhibitors
TABLE 4 ORAL DIABETES TREATMENTS
DIET
FUTURE TREATMENT APPROACHES
MONITORING DIABETES
BLOOD SUGAR CONTROL
THE DIABETES CONTROL AND COMPLICATIONS TRIAL
GLYCATED HAEMOGLOBIN (HBA1C)
FRUCTOSAMINE
PREVALENCE OF DIABETES
TABLE 5 PREVALENCE OF DIABETES BY REGION, 2010 AND 2030 (POPULATION AGED 20 TO 79)
TYPE 1
TYPE 2
DIABETIC COMPLICATIONS
RETINOPATHY
NEUROPATHY
NEPHROPATHY
PREVALENCE BY REGION
TABLE 6 PREVALENCE RANGE OF DIABETIC COMPLICATIONS BY REGION, 2006
INCREASED MORTALITY RISK
METABOLIC SYNDROME

Chapter-5: DIABETES THERAPIES
INSULIN
HISTORY
Bovine and Porcine Insulin
Humanized Insulin
COMPANIES SUPPLYING INSULIN
Eli Lilly
Sanofi Aventis
Novo Nordisk
Some Other Suppliers
Wockhardt Limited: India
BioconB: India
Shreya Life Sciences: India
Diosynth: the Netherlands
TABLE 7 MAJOR BRANDS OF INSULIN
INSULIN DELIVERY
Syringes
INSULIN SYRINGE MANUFACTURERS
Becton Dickinson
Owen Mumford
Terumo
B. Braun
Pens
TABLE 8 INSULIN PENS
MANUFACTURERS OF INSULIN PENS
Novo Nordisk
Owen Mumford
Other Makers
INJECTORS
INJECTOR MANUFACTURERS
Activa Brand Products
Antares Pharma
Bioject
MediCool, Inc
Owen Mumford
Palco Labs, Inc
Rosch AG Medizintechnik
INHALED INSULIN
OTHER INSULIN DELIVERY APPROACHES
Oral-Lyn
Oramed
Medingo Micro-pump Patch
INSULIN PUMPS
The Infusion Set
Candidates for Pump Therapy
COMPANIES SUPPLYING INSULIN PUMPS
Animas Corporation
Sooil Development Company
Medtronic MiniMed
Nipro Diabetes Systems
Roche Disetronic
Smiths Medical
Insulet
TABLE 9 INSULIN PUMPS
Problems with Pumps or Users?

Chapter-6: ORAL HYPOGLYCEMIC DRUGS
SULFONYLUREAS
TABLE 10 SULFONYLUREAS
BIGUANIDES
ALPHA-GLUCOSIDASE INHIBITOR
GLITAZONES
PRANDIAL GLUCOSE REGULATORS
GLP-1 ANALOGS; ALSO KNOWN AS INCRETIN MIMETICS
AMYLIN MIMETIC
TABLE 11 ORAL HYPOGLYCEMICS
NEW PRODUCTS NOW IN R&D
Dutogliptin
Taspoglutide
Byetta LAR
Lixisenatide

Chapter-7: DIAGNOSIS AND MONITORING
THE ROLE OF SELF-MONITORING
SMBG FREQUENCY
BLOOD GLUCOSE MONITORING DEVICES: SUPPLIERS AND PRODUCTS
LANCETS
TABLE 12 INTERNATIONAL SUPPLIERS OF BLOOD LANCETS
BLOOD SAMPLING DEVICES
Bayer Diagnostics
Becton Dickinson
Cell Robotics
LifeScan
Roche Diagnostics
BLOOD GLUCOSE MONITORS
77 Elektronica Kft
Abbott Laboratories
Acon Laboratories Inc.
AgaMatrix Inc.
Apex Biotechnology Corp.
Arkray USA
Aventir Biotech LLC
Bayer Corporation
Belbiosens
Diagnostic Devices Inc.
Eumed Biotechnology Co. Ltd.
HMD Bio Medical
GlucoPlus Inc
Health & Life Co.
HemoCue AB
Home Diagnostics Inc
Hypoguard
i-SENS Inc.
LifeScan Inc
Medtronic MiniMed
Menarini Diagnostics
National Diagnostic Products
Novabiomedical Corporation
Roche
TaiDoc Technology Corporation
US Diagnostics Inc
GLUCOSE METER ACCURACY
NEW DEVELOPMENTS IN GLUCOSE TESTING
CONTINUOUS GLUCOSE MONITORING (CGM)
Reimbursement
NON-INVASIVE MONITORING
TABLE 13 SELECTED COMPANIES DEVELOPING NON-INVASIVE GLUCOSE MONITORING
ARTIFICIAL PANCREAS
Roche
Abbott
Novo Nordisk/LifeScan
OTHER TESTING APPROACHES
HAEMOGLOBIN A1C
Hemoglobin A1c Meters
Hemoglobin A1c Kits
SOFTWARE AIDS TO DIABETES MONITORING
AIDA ON-LINE
BAYER CARE: BLOOD SUGAR LOG
BODY SIGMA
DAILYRATING
DIABETEASE
DIABETES ASSISTANT
DIABETES HOMECARE CENTER
ECIVON
HEALTHENGAGE DIABETES
LIFECLINIC
PLASMAGLUCOSE
SYMCARE

Chapter-8: THE DIABETES MARKET
MARKET COMPONENTS
SIZE
TABLE 14 GLOBAL DIABETES MARKET 2010 ($)
GROWTH
REGIONAL SEGMENTATION
TABLE 15 REGIONAL SEGMENTATION OF DIABETES UNIVERSE, 2010 AND 2030 (MILLIONS/%)
NATIONAL MARKETS
NORTH AMERICA
TABLE 16 U.S.: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 17 CANADA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
SOUTH AND CENTRAL AMERICA
TABLE 18 ARGENTINA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 19 BRAZIL: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 20 MEXICO: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
EUROPE
TABLE 21 BELGIUM: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 22 DENMARK: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 23 FRANCE: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 24 GERMANY: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 25 ITALY: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 26 NETHERLANDS: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 27 NORWAY: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 28 PORTUGAL: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 29 RUSSIA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 30 SPAIN: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 31 SWEDEN: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 32 UNITED KINGDOM: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 33 EUROPEAN UNION: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
WESTERN PACIFIC
TABLE 34 AUSTRALIA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 35 CHINA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 36 JAPAN: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 37 SOUTH KOREA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 38 TAIWAN: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
SOUTH-EAST ASIA
TABLE 39 INDIA: DIABETES MARKET, THROUGH 2015 ($ MILLIONS)
MARKET ANALYSIS BY PRODUCT CATEGORY
MONITORING PRODUCTS
Major Suppliers
TABLE 40 LEADING COMPANIES OF GLUCOSE MONITORING PRODUCTS, 2009 ($ MILLIONS/%)
INSULINS AND INSULIN DELIVERY DEVICES
Major Suppliers
TABLE 41 GLOBAL SALES OF LEADING INSULIN PRODUCTS, 2009 ($ MILLIONS)
INSULIN PUMPS
TABLE 42 GLOBAL INSULIN PUMP MARKET, BY REGION, THROUGH 2015 ($ MILLIONS)
OTHER ANTIDIABETIC DRUGS
Major suppliers
TABLE 43 SALES OF OTHER ANTIDIABETIC PRODUCTS, 2009 ($ MILLIONS)
TRENDS

Chapter-9: NEW APPROACHES TO THE MANAGEMENT OF DIABETES
ALTERNATIVES TO INSULIN
IMMUNOTHERAPY
TRANSPLANTATION
CELL AND STEM CELL THERAPIES
GENE THERAPY
GENE THERAPY APPROACHES FOR EXPRESSING INSULIN
GENE THERAPY APPROACHES FOR IMMUNOMODULATION
GENE THERAPY APPROACHES FOR CELL-BASED THERAPIES

Chapter-10: COMPANY PROFILES
LEADING COMPANIES
ABBOTT LABORATORIES
Overview
Diabetes Products
ABBOTT DIABETES CARE, INC.
BAYER
Overview
Diabetes Products
BECTON DICKINSON
Overview
Diabetes Products
Insulin Injection Devices
BRISTOL-MYERS SQUIBB
Overview
Problems with Generics
Diabetes Products
ELI LILLY AND COMPANY
Overview
Diabetes Products
Pipeline
GLAXO SMITHKLINE
Overview
Diabetes Products
Pipeline
TABLE 44 DIABETES PRODUCTS IN GSK PIPELINE
JOHNSON & JOHNSON
Overview
Diabetes Products
MEDTRONIC
Overview
Diabetes Products
Pipeline
MERCK KGAA
Overview
Diabetes Product
NOVARTIS INTERNATIONAL AG
Overview
Diabetes Products
Research
NOVO NORDISK A/S
Overview
Diabetes Products
Pharmaceuticals
Injection devices
Pipeline
ROCHE
Overview
Diabetes Products
Blood Glucose Monitoring Systems
Diabetes Data Management
Insulin Pump Systems
Lancet Devices
Other
Pipeline
SANOFI-AVENTIS
Overview
Diabetes Products
TAKEDA
Overview
Pipeline
TABLE 45 DIABETES PRODUCTS IN DEVELOPMENT BY TAKEDA
OTHER COMPANIES
77 ELEKTRONIKA CO., LTD.
AGAMATRIX, INC.
ANIMAS CORPORATION
DEBIOTECH S.A.
INLIGHT SOLUTIONS, INC.
LIFESCAN, INC.
A. MENARINI DIAGNOSTICS S.R.L.
NIPRO CORPORATION
OWEN MUMFORD LTD
PALCO LABS, INC.
TERUMO CORP.

APPENDIX
TABLE 46 GLOSSARY

発刊日

2010/06/01

体裁

PDF / 150ページ

販売価格

4,850USD

発行

BCC Research

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

疾病別治療・領域別治療 / 診断・検査薬

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE